Author:
Amaro Adriana,Esposito Alessia Isabella,Gallina Anna,Nees Matthias,Angelini Giovanna,Albini Adriana,Pfeffer Ulrich
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Brawley, O. W. (2012). Prostate cancer epidemiology in the United States. World Journal of Urology, 30(2), 195–200. doi: 10.1007/s00345-012-0824-2 .
2. Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., et al. (2012). International variation in prostate cancer incidence and mortality rates. European Urology, 61(6), 1079–1092. doi: 10.1016/j.eururo.2012.02.054 .
3. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987). Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New England Journal of Medicine, 317(15), 909–916. doi: 10.1056/NEJM198710083171501 [Comparative Study Research Support, Non-U.S. Gov't].
4. Wang, M. C., Valenzuela, L. A., Murphy, G. P., & Chu, T. M. (1979). Purification of a human prostate specific antigen. Investigative Urology, 17(2), 159–163 [Research Support, U.S. Gov't, P.H.S.].
5. Lin, K., Lipsitz, R., Miller, T., & Janakiraman, S. (2008). Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 149(3), 192–199 [Practice Guideline Review].
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献